What we're reading, October 19, 2016: the District of Columbia will vote on right-to-die legislation; huge premium increases for Obamacare plans; and why primary care physicians haven't gotten involved in the opioid epidemic.
The District of Columbia is the next place in the United States to consider allowing doctors to prescribe lethal drugs to terminally ill patients. According to The Washington Post, the DC Council will hold the first of 2 required votes on the bill on November 1, but it is unclear if the mayor will sign the bill. If DC passed the legislation, it would become the sixth jurisdiction in the country to authorize the practice. Ultimately, Congress still has the power to strike down any DC laws approved by the council and the mayor.
Health plans have been granted huge premium increases. While most of the people receiving coverage through a plan purchased on one of the Affordable Care Act exchanges don’t pay the full premium, some insurers have been granted rate increases of 30% or 50% over 2016 rates, reported The Wall Street Journal. This is shaping up to be a critical year for the Affordable Care Act, many experts believe.
Few primary care physicians are stepping in to treat substance abuse disorders and less than 1% are certified to treat addiction with buprenorphine. STAT reported that part of the problem is that the 8-hour certification course is not enough to give providers the confidence to handle the complexities of treating patients with opioid use disorders. In addition, there are few incentives to get trained, and as a result primary care physicians are staying out of the fight against the opioid epidemic.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More